Compare IGA & IPEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IGA | IPEX |
|---|---|---|
| Founded | 2005 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.5M | 123.4M |
| IPO Year | N/A | N/A |
| Metric | IGA | IPEX |
|---|---|---|
| Price | $9.31 | $10.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 52.5K | 14.6K |
| Earning Date | 01-01-0001 | 04-15-2026 |
| Dividend Yield | ★ 8.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $41.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.43 | $10.25 |
| 52 Week High | $10.12 | $10.39 |
| Indicator | IGA | IPEX |
|---|---|---|
| Relative Strength Index (RSI) | 31.68 | 65.07 |
| Support Level | N/A | N/A |
| Resistance Level | $9.83 | N/A |
| Average True Range (ATR) | 0.16 | 0.01 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 16.67 | 100.00 |
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.
Inflection Point Acquisition Corp V is a blank check company.